Incidence of COVID-19 in patients exposed to chloroquine and hydroxychloroquine: results from a population-based prospective cohort in Catalonia, Spain, 2020

BACKGROUND: Several clinical trials have assessed the protective potential of chloroquine and hydroxychloroquine. Chronic exposure to such drugs might lower the risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or severe coronavirus disease (COVID-19). AIM: To asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivanco-Hidalgo, Rosa Maria, Molina, Israel, Martinez, Elisenda, Roman-Viñas, Ramón, Sánchez-Montalvá, Adrián, Fibla, Joan, Pontes, Caridad, Velasco Muñoz, César
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934222/
https://www.ncbi.nlm.nih.gov/pubmed/33663646
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.9.2001202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934222/
https://www.ncbi.nlm.nih.gov/pubmed/33663646
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.9.2001202

Ejemplares similares